Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

16 Jul 2015 07:00

RNS Number : 1847T
BrainJuicer Group PLC
16 July 2015
 

 

 

 

 

Press Release 16 July 2015

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Pre close trading update

 

BrainJuicer (AIM: BJU), the international online market research agency, today releases the following half-year ("H1") trading update. The Company will announce its interim results for the 6 months to 30 June 2015 on 24 September 2015.

 

Overall, the Company achieved revenue growth of approximately 4% compared with the same period in 2014. The overall impact of exchange rate movements was not material. Sales of BrainJuicer's core quantitative products, approximately 90% of our business, increased by around 7%, with gross profit on these products increasing by 11%. This was partially offset by a decline in revenue from Juice Generation, as we transition these services to our new Brand Strategy initiative.

 

Our two main markets experienced contrasting fortunes during the half. The US delivered strong growth ahead of H1 2014, but in the UK sales were below the H1 2014 level. Elsewhere, Continental Europe grew strongly, and Brazil also made good progress.

 

Overheads grew faster than revenue during the half, as the business continued to invest for future growth. We recruited two senior managers to spearhead the Brand Strategy initiative, and average headcount was 10% higher than in the comparable period. H1 2015 also included some one-off costs, including costs relating to moving our HQ to larger offices in London, which occurred in June (this move has now been completed). Due in part to one off costs, including the above, first half profit before tax will be approximately 25% lower than that achieved in 2014.

 

 

 

 

 

 

The Company's financial position remains strong. At the end of June 2015, the Company had a cash balance of £5.3m (December 2014: £5.3m), after having returned £0.4m to shareholders during the half year by way of dividends.

 

The Company has enjoyed good growth in its core quantitative products in the first half, and it does not anticipate incurring further material one-off costs in the second half. The Company generates the majority of its profit in the second half, and whilst revenue visibility remains typically limited the Board believes the Company is in a position to meet profit expectations for the full year.

 

The Company can be found at www.brainjuicer.com

 

- Ends -

 

 

For further information, please contact:

 

BrainJuicer Group PLC

John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVRARVKABAUR
Date   Source Headline
18th Aug 20177:00 amRNSTrading Update
11th Jul 20171:18 pmRNSAnnual Report and Notice of AGM
3rd Jul 20177:59 amRNSTotal Voting Rights
26th Jun 201711:23 amRNSDirector/PDMR Shareholding
16th Jun 20171:33 pmRNSExercise of Options and Director Dealing
15th Jun 20177:00 amRNSDividend Declaration
15th Jun 20177:00 amRNSDirectorate Change
15th Jun 20177:00 amRNSFinancial results to 31 March 2017
11th May 20175:47 pmRNSHolding(s) in Company
19th Apr 20177:00 amRNSTrading Update
3rd Apr 20177:00 amRNSChange of Name
24th Mar 20177:00 amRNSChange of Name
22nd Mar 20174:31 pmRNSGrant of Options
22nd Mar 20173:44 pmRNSResult of General Meeting
1st Mar 20172:02 pmRNSTotal Voting Rights
28th Feb 20172:58 pmRNSDirector/PDMR Shareholding
24th Feb 20177:00 amRNSNotice of GM
10th Feb 20173:46 pmRNSExercise of Options
9th Feb 20177:00 amRNSResults for the 12 months ended 31 December 2016
7th Feb 20177:00 amRNSBoard Appointment
20th Jan 20177:00 amRNSTrading Update
9th Dec 20167:00 amRNSTrading Update
1st Dec 201612:45 pmRNSTotal Voting Rights
1st Nov 20165:34 pmRNSTransaction in Own Shares
1st Nov 20161:35 pmRNSTotal Voting Rights
13th Oct 20165:34 pmRNSTransaction in Own Shares
12th Oct 20161:44 pmRNSTransaction in Own Shares
4th Oct 20167:00 amRNSDirectorPDMR Dealing and Transaction in Own Shares
30th Sep 20165:15 pmRNSTransaction in Own Shares
27th Sep 20164:57 pmRNSExercise of Options, PDMR Shareholding
22nd Sep 20167:00 amRNSExercise of Options and Transaction in Own Shares
22nd Sep 20167:00 amRNSTransaction in Own Shares
20th Sep 20166:23 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSTransaction in Own Shares
16th Sep 20167:00 amRNSInterim Results
16th Sep 20167:00 amRNSDividends and Share Buyback
9th Sep 20164:39 pmRNSHolding(s) in Company
9th Sep 20161:20 pmRNSHolding(s) in Company
26th Aug 201611:42 amRNSHolding(s) in Company
16th Aug 20164:15 pmRNSAdditional Listing
15th Jul 20167:00 amRNSTrading Update
20th Jun 20164:40 pmRNSTransaction in Own Shares
6th Jun 20164:45 pmRNSDirector Dealing
6th Jun 201611:17 amRNSDirector Dealing
3rd Jun 20162:17 pmRNSHolding(s) in Company
2nd Jun 20166:02 pmRNSDirector Dealing and Transaction in Own Shares
18th May 20165:46 pmRNSDirector Dealing and Transaction in Own Shares
6th May 201612:19 pmRNSResult of AGM
4th May 20163:55 pmRNSTransaction in Own Shares
22nd Apr 20163:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.